Back to Newsroom
Back to Newsroom

CLASS ACTION UPDATE for FB, ONTF and SBTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Tuesday, 09 November 2021 06:00 AM

Levi & Korsinsky, LLP

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / November 9, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

FB Shareholders Click Here: https://www.zlk.com/pslra-1/facebook-inc-loss-submission-form?prid=20964&wire=1
ONTF Shareholders Click Here: https://www.zlk.com/pslra-1/on24-inc-loss-submission-form?prid=20964&wire=1
SBTX Shareholders Click Here: https://www.zlk.com/pslra-1/silverback-therapeutics-inc-loss-submission-form?prid=20964&wire=1

* ADDITIONAL INFORMATION BELOW *

Levi & Korsinsky, LLP, Tuesday, November 9, 2021, Press release picture

Facebook, Inc. (NASDAQ:FB)

FB Lawsuit on behalf of: investors who purchased November 3, 2016 - October 4, 2021
Lead Plaintiff Deadline : December 27, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/facebook-inc-loss-submission-form?prid=20964&wire=1

According to the filed complaint, during the class period, Facebook, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Facebook misrepresented its user growth; (2) Facebook knew, or should have known, that duplicate accounts represented a greater portion of its growth than stated, and it should have provided more detailed disclosures as to the implication of duplicate accounts to Facebook's user base and growth; (3) Facebook did not provide a fair platform for speech, and regularly protected high profile users via its Cross Check/XCheck system; (4) despite being aware of their use of Facebook's platforms, the Company failed to respond meaningfully to drug cartels, human traffickers, and violent organizations; (5) Facebook has been working to attract preteens to its platform and services; and (6) as a result, Defendants' public statements were materially false and misleading at all relevant times.

On24, Inc. (NYSE:ONTF)

This lawsuit is on behalf of persons and entities who also acquired ON24's shares pursuant and traceable to the Offering issued in connection with the Company's February 2, 2021, initial public offering.
Lead Plaintiff Deadline : January 3, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/on24-inc-loss-submission-form?prid=20964&wire=1

According to the filed complaint, the surge in COVID-19 customers observed in the lead up to the IPO consisted of a significant number that did not fit ON24's traditional customer profile, and, as a result, were significantly less likely to renew their contracts.

Silverback Therapeutics, Inc. (NASDAQ:SBTX)

This lawsuit is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Silverback common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about December 3, 2020 and/or (b) Silverback securities between December 3, 2020 and September 10, 2021, both dates inclusive.
Lead Plaintiff Deadline : January 4, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/silverback-therapeutics-inc-loss-submission-form?prid=20964&wire=1

According to the filed complaint, (i) Silverback's lead product candidate SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers, was less effective than the Company had represented to investors; (ii) accordingly, the Company had overstated SBT6050's commercial and/or clinical prospects; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

Topic:
Lawsuits
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: